Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Aschelter

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Tumori|May 9, 2002
[Chronotherapy]C Garufi, A M Aschelter, A R Zappalà, et al.
Il Giornale Di Chirurgia|March 1, 1988
[Treatment of hepatic metastases from colo-rectal tumors: intra-arterial loco-regional therapy]E Cortesi, A M Aschelter, C Ficorella, et al.
Chronobiology International|April 19, 2002
Quality of life and chronotherapyP Pugliese, C Garufi, M Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Skin testing and hypersensitivity reactions to oxaliplatinC Garufi, A Cristaudo, B Vanni, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1990
Efficacy and toxicity of 5-fluorouracil and folates in advanced colon cancerE Cortesi, A M Aschelter, N Gioacchini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II studyC Garufi, C Nisticò, S Brienza, et al.
Tumori|June 30, 1985
Role of delayed cutaneous hypersensitivity reaction in classifying patients with bronchial carcinomaC Modini, V Ziparo, F Cicconetti, et al.
Cancer|March 10, 2001
Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma: a phase I studyC Garufi, L Dogliotti, R M D'Attino, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancerC Garufi, F Lévi, A M Aschelter, et al.
Anti-Cancer Drugs|September 23, 2000
Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patientsC Garufi, S Brienza, P Pugliese, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Tumori|May 9, 2002
[Chronotherapy]C Garufi, A M Aschelter, A R Zappalà, et al.
Il Giornale Di Chirurgia|March 1, 1988
[Treatment of hepatic metastases from colo-rectal tumors: intra-arterial loco-regional therapy]E Cortesi, A M Aschelter, C Ficorella, et al.
Chronobiology International|April 19, 2002
Quality of life and chronotherapyP Pugliese, C Garufi, M Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Skin testing and hypersensitivity reactions to oxaliplatinC Garufi, A Cristaudo, B Vanni, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1990
Efficacy and toxicity of 5-fluorouracil and folates in advanced colon cancerE Cortesi, A M Aschelter, N Gioacchini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II studyC Garufi, C Nisticò, S Brienza, et al.
Tumori|June 30, 1985
Role of delayed cutaneous hypersensitivity reaction in classifying patients with bronchial carcinomaC Modini, V Ziparo, F Cicconetti, et al.
Cancer|March 10, 2001
Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma: a phase I studyC Garufi, L Dogliotti, R M D'Attino, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancerC Garufi, F Lévi, A M Aschelter, et al.
Anti-Cancer Drugs|September 23, 2000
Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patientsC Garufi, S Brienza, P Pugliese, et al.
Pageof 1